Emma Shanks

3.5k total citations
23 papers, 1.3k citations indexed

About

Emma Shanks is a scholar working on Molecular Biology, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Emma Shanks has authored 23 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Epidemiology and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Emma Shanks's work include Trypanosoma species research and implications (6 papers), Research on Leishmaniasis Studies (4 papers) and Microtubule and mitosis dynamics (3 papers). Emma Shanks is often cited by papers focused on Trypanosoma species research and implications (6 papers), Research on Leishmaniasis Studies (4 papers) and Microtubule and mitosis dynamics (3 papers). Emma Shanks collaborates with scholars based in United Kingdom, United States and Netherlands. Emma Shanks's co-authors include Julie A. Frearson, Alan H. Fairlamb, Lynn McGarry, Ian H. Gilbert, Paul G. Wyatt, Caleb J. Kennedy, Roderick L. Beijersbergen, David M. Wrobel, Javier Santoyo‐López and Dara J. Dunican and has published in prestigious journals such as Cell, Nature Communications and Nature Reviews Drug Discovery.

In The Last Decade

Emma Shanks

23 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emma Shanks United Kingdom 17 778 221 198 193 142 23 1.3k
Gregory McAllister Switzerland 11 1.1k 1.5× 335 1.5× 99 0.5× 50 0.3× 106 0.7× 17 1.5k
J. Fraser Glickman United States 22 1.5k 1.9× 112 0.5× 94 0.5× 99 0.5× 152 1.1× 47 2.2k
Marie K. Schwinn United States 15 2.1k 2.7× 91 0.4× 54 0.3× 174 0.9× 177 1.2× 22 2.7k
Russell Bell United States 19 1.1k 1.5× 96 0.4× 223 1.1× 28 0.1× 140 1.0× 29 1.7k
David P. Nusinow United States 11 1.9k 2.4× 295 1.3× 45 0.2× 126 0.7× 237 1.7× 12 2.6k
Adam Castoreno United States 18 841 1.1× 332 1.5× 47 0.2× 53 0.3× 151 1.1× 29 1.4k
E. Salah United Kingdom 19 1.0k 1.3× 51 0.2× 62 0.3× 172 0.9× 149 1.0× 47 1.4k
Stefan Henrich Germany 13 793 1.0× 62 0.3× 62 0.3× 119 0.6× 90 0.6× 20 1.3k
Robert C. Boltz United States 18 679 0.9× 97 0.4× 78 0.4× 64 0.3× 94 0.7× 25 1.4k
Dattatreya Mellacheruvu United States 14 1.7k 2.1× 118 0.5× 50 0.3× 97 0.5× 78 0.5× 19 2.2k

Countries citing papers authored by Emma Shanks

Since Specialization
Citations

This map shows the geographic impact of Emma Shanks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma Shanks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma Shanks more than expected).

Fields of papers citing papers by Emma Shanks

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emma Shanks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma Shanks. The network helps show where Emma Shanks may publish in the future.

Co-authorship network of co-authors of Emma Shanks

This figure shows the co-authorship network connecting the top 25 collaborators of Emma Shanks. A scholar is included among the top collaborators of Emma Shanks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emma Shanks. Emma Shanks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kalkman, Eric R., Joe M. Jones, Daniel James, et al.. (2024). Nutrient-sensitizing drug repurposing screen identifies lomerizine as a mitochondrial metabolism inhibitor of chronic myeloid leukemia. Science Translational Medicine. 16(751). eadi5336–eadi5336. 3 indexed citations
2.
Papalazarou, Vassilis, Alice C. Newman, Alejandro Huerta Uribe, et al.. (2023). Phenotypic profiling of solute carriers characterizes serine transport in cancer. Nature Metabolism. 5(12). 2148–2168. 22 indexed citations
3.
Sandilands, Emma, Álvaro Román‐Fernández, Susan Mason, et al.. (2021). An ARF GTPase module promoting invasion and metastasis through regulating phosphoinositide metabolism. Nature Communications. 12(1). 1623–1623. 10 indexed citations
4.
Hanley, Neil A., Emma Shanks, Andrew McCarthy, et al.. (2020). Longitudinal changes in EEG power, sleep cycles and behaviour in a tau model of neurodegeneration. Alzheimer s Research & Therapy. 12(1). 84–84. 29 indexed citations
5.
Rushworth, Linda, Sukrut Somani, Daniel James, et al.. (2019). Repurposing screen identifies mebendazole as a clinical candidate to synergise with docetaxel for prostate cancer treatment. British Journal of Cancer. 122(4). 517–527. 36 indexed citations
6.
Sandilands, Emma, Daniel James, Hing Y. Leung, et al.. (2018). A functional genomics screen reveals a strong synergistic effect between docetaxel and the mitotic gene DLGAP5 that is mediated by the androgen receptor. Cell Death and Disease. 9(11). 1069–1069. 17 indexed citations
7.
Román‐Fernández, Álvaro, Julie Roignot, Emma Sandilands, et al.. (2018). The phospholipid PI(3,4)P2 is an apical identity determinant. Nature Communications. 9(1). 5041–5041. 58 indexed citations
8.
Gillespie, Peter J., Emma Shanks, Stuart P. McElroy, et al.. (2017). The High-Affinity Interaction between ORC and DNA that Is Required for Replication Licensing Is Inhibited by 2-Arylquinolin-4-Amines. Cell chemical biology. 24(8). 981–992.e4. 12 indexed citations
9.
Shanks, Emma, Robin Ketteler, & Daniel Ebner. (2015). Academic drug discovery within the United Kingdom: a reassessment. Nature Reviews Drug Discovery. 14(7). 510–510. 16 indexed citations
10.
Mardilovich, Katerina, Mads Gabrielsen, Lynn McGarry, et al.. (2014). Elevated LIM Kinase 1 in Nonmetastatic Prostate Cancer Reflects Its Role in Facilitating Androgen Receptor Nuclear Translocation. Molecular Cancer Therapeutics. 14(1). 246–258. 34 indexed citations
11.
Jerby‐Arnon, Livnat, Yedael Y. Waldman, Lynn McGarry, et al.. (2014). Predicting Cancer-Specific Vulnerability via Data-Driven Detection of Synthetic Lethality. Cell. 158(5). 1199–1209. 201 indexed citations
12.
Shanks, Emma. (2014). Strategic siRNA Screening Approaches to Target Cancer at the Cancer Research UK Beatson Institute. Combinatorial Chemistry & High Throughput Screening. 17(4). 328–332. 1 indexed citations
13.
Patterson, Stephen, M.S. Alphey, Deuan C. Jones, et al.. (2011). Dihydroquinazolines as a Novel Class of Trypanosoma brucei Trypanothione Reductase Inhibitors: Discovery, Synthesis, and Characterization of their Binding Mode by Protein Crystallography. Journal of Medicinal Chemistry. 54(19). 6514–6530. 111 indexed citations
14.
Spinks, Daniel, Han B. Ong, Chidochangu P. Mpamhanga, et al.. (2010). Design, Synthesis and Biological Evaluation of Novel Inhibitors of Trypanosoma brucei Pteridine Reductase 1. ChemMedChem. 6(2). 302–308. 32 indexed citations
15.
Shanks, Emma, Han B. Ong, David A. Robinson, et al.. (2009). Development and validation of a cytochrome c-coupled assay for pteridine reductase 1 and dihydrofolate reductase. Analytical Biochemistry. 396(2). 194–203. 18 indexed citations
16.
Birmingham, Amanda, Laura M. Selfors, Thorsten Forster, et al.. (2009). Statistical methods for analysis of high-throughput RNA interference screens. Nature Methods. 6(8). 569–575. 439 indexed citations
17.
Patterson, Stephen, Deuan C. Jones, Emma Shanks, et al.. (2009). Synthesis and Evaluation of 1‐(1‐(Benzo[b]thiophen‐2‐yl)cyclohexyl)piperidine (BTCP) Analogues as Inhibitors of Trypanothione Reductase. ChemMedChem. 4(8). 1341–1353. 42 indexed citations
18.
Spinks, Daniel, Emma Shanks, Laura A. T. Cleghorn, et al.. (2009). Investigation of Trypanothione Reductase as a Drug Target in Trypanosoma brucei. ChemMedChem. 4(12). 2060–2069. 43 indexed citations
19.
Mpamhanga, Chidochangu P., Daniel Spinks, L.B. Tulloch, et al.. (2009). One Scaffold, Three Binding Modes: Novel and Selective Pteridine Reductase 1 Inhibitors Derived from Fragment Hits Discovered by Virtual Screening. Journal of Medicinal Chemistry. 52(14). 4454–4465. 83 indexed citations
20.
Reed, Matthew, et al.. (2001). Stereological estimation of eye volume using the Pappus method. Journal of Microscopy. 202(3). 473–479. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026